Hepatitis C virus and HIV co-infection: a sleeping giant wakes.
Sulkowski
M S
MS
D000998:Antiviral Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D015658:HIV Infections / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D015507:Drugs, Investigational; D007370:Interferon Type I; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin